# Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms

> **NCT00277667** · PHASE3 · COMPLETED · sponsor: **Lindner Center of HOPE** · enrollment: 40 (estimated)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Quetiapine

## Key facts

- **NCT ID:** NCT00277667
- **Lead sponsor:** Lindner Center of HOPE
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2009-03-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00277667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00277667, "Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00277667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*